Table 2:

Clinical characteristics and imaging findings of patients with different symptom stages

All (n = 126)Symptomatic (n = 66)Asymptomatic (n = 60)P Value
Age (mean) (yr)61.5 ± 10.061.7 ± 10.561.4 ± 9.4.86
Sex (male) (No.) (%)82 (65.1%)50 (75.8%)32 (53.3%)<.001a
Diabetes (No.) (%)42 (33.3%)23 (34.8%)19 (31.7%).71
Smoking (No.) (%)35 (27.8%)25 (37.9%)10 (16.7%)<.001a
Hypertension (No.) (%)101 (80.2%)52 (78.8%)49 (81.7%).69
Hyperlipidemia (No.) (%)65 (51.6%)38 (57.6%)27 (45.0%).16
Coronary artery disease (No.) (%)5 (4.0%)3 (4.5%)2 (3.3%).73
Preadmission aspirin use (No.) (%)31 (24.6%)21 (31.8%)10 (16.7%).06
Preadmission statin use (No.) (%)17 (13.5%)10 (15.2%)7 (11.7%).57
NIHSS score (median) (range)1 (0–11)2 (0–11)0 (0–4)<.001a
Degree of stenosis (mean) (%)52.6 ± 15.852.4 ± 15.552.8 ± 16.1.88
Enhancement percentage (mean)17.4 ± 28.425.5 ± 26.18.5 ± 28.5<.001a
Intraplaque hemorrhage (No.) (%)22 (17.5%)21 (31.8%)1 (1.7%)<.001a
Minimum lumen area (mean) (mm2)3.2 ± 2.73.7 ± 2.82.7 ± 2.6.04a
Plaque burden (mean) (%)84.0 ± 9.183.6 ± 9.884.4 ± 8.2.62
  • a Statistically significant.